ITCI
Intra-Cellular Therapies Inc
Price:  
76.51 
USD
Volume:  
774,252.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI EV/EBITDA

-126.5%
Upside

As of 2024-07-18, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -60.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 7,937.34 mil USD. ITCI's TTM EBITDA according to its financial statements is -131.42 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.5x - 17.0x 13.4x
Forward P/E multiples 18.3x - 21.8x 21.4x
Fair Price (21.48) - (19.84) (20.30)
Upside -128.1% - -125.9% -126.5%
76.51 USD
Stock Price
(20.30) USD
Fair Price

ITCI EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-17 -60.40
2024-07-16 -62.05
2024-07-15 -62.15
2024-07-12 -61.70
2024-07-11 -61.85
2024-07-10 -61.02
2024-07-09 -58.44
2024-07-08 -56.42
2024-07-05 -54.81
2024-07-03 -54.42
2024-07-02 -53.99
2024-07-01 -53.55
2024-06-28 -53.95
2024-06-27 -55.95
2024-06-26 -56.04
2024-06-25 -57.11
2024-06-24 -59.64
2024-06-21 -60.45
2024-06-20 -59.63
2024-06-18 -59.57
2024-06-17 -54.26
2024-06-14 -53.38
2024-06-13 -53.89
2024-06-12 -53.72
2024-06-11 -54.47
2024-06-10 -54.42
2024-06-07 -53.89
2024-06-06 -54.00
2024-06-05 -53.41
2024-06-04 -53.46
2024-06-03 -53.89
2024-05-31 -52.95
2024-05-30 -51.67
2024-05-29 -52.39
2024-05-28 -51.65
2024-05-24 -51.58
2024-05-23 -52.25
2024-05-22 -53.00
2024-05-21 -52.76
2024-05-20 -51.41
2024-05-17 -51.15
2024-05-16 -52.38
2024-05-15 -52.63
2024-05-14 -51.72
2024-05-13 -52.21
2024-05-10 -51.12
2024-05-09 -51.60
2024-05-08 -52.76
2024-05-07 -56.14
2024-05-06 -55.98